Legend Biotech (LEGN) Change in Cash (2019 - 2026)
Legend Biotech's (LEGN) quarterly Change in Cash came in at -$255.5 million in Q1 2026, down 264.84% YoY from $155.0 million in Q1 2025, and down 141.01% on a QoQ basis from $623.0 million in Q4 2025.
Legend Biotech (LEGN) Change in Cash (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Change in Cash data on file, last reported at -$255.5 million in Q1 2026.
- Quarterly Change in Cash fell 264.84% year-over-year to -$255.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $204.6 million (up 144.85% YoY) and the FY2025 annual result came in at $615.2 million, up 162.08% from the prior year.
- Change in Cash retreated to -$255.5 million in Q1 2026, from $623.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $909.7 million in Q2 2023 to a low of -$696.3 million in Q2 2024.
- A 5-year average of -$2.4 million and a median of -$25.6 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash slumped 611.55% — and 2023, when it surged 31773.09%.
- Tracing LEGN's Change in Cash over 5 years: stood at -$25.6 million in 2022, then jumped by 1322.17% to $312.8 million in 2023, then slumped by 155.18% to -$172.6 million in 2024, then soared by 460.95% to $623.0 million in 2025, then plunged by 141.01% to -$255.5 million in 2026.
- The last three Change in Cash figures came in at -$255.5 million (Q1 2026), $623.0 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.50 Mn |
| Mar 31, 2026 | -255.50 Mn |
| Dec 31, 2025 | 623.00 Mn |
| Sep 30, 2025 | 18.15 Mn |
| Jun 30, 2025 | -181.00 Mn |
| Mar 31, 2025 | 155.00 Mn |
| Dec 31, 2024 | -172.60 Mn |
| Sep 30, 2024 | 257.69 Mn |
| Jun 30, 2024 | -696.33 Mn |
| Mar 31, 2024 | -379.80 Mn |
| Dec 31, 2023 | 312.79 Mn |
| Sep 30, 2023 | -607.82 Mn |
| Jun 30, 2023 | 909.66 Mn |
| Mar 31, 2023 | -123.63 Mn |
| Dec 31, 2022 | -25.59 Mn |
| Sep 30, 2022 | 433.50 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | -311.16 Mn |
| Dec 31, 2021 | 350.53 Mn |
| Sep 30, 2021 | -149.12 Mn |